Aminex Therapeutics Competitors and Similar CompaniesClear all
Aminex Therapeutics's competitors and similar companies include CureVac, Puma Biotechnology, HUYA Bioscience International and Celltrion Healthcare.
 Aminex Therapeutics Aminex Therapeutics is a company intended to develop small molecule immunotherapeutic products for cancer treatment. |  Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  HUYA Bioscience International HUYA Bioscience International is a company specializing in the biopharmaceutical products. |  Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., | ||
Founding Date | Founding Date 2009 | Founding Date 2000 | Founding Date 2010 | Founding Date 2004 | Founding Date 2002 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Los Angeles, US HQ | Locations San Diego, US HQ Chengdu Shi, CN Guangzhou Shi, CN Hangzhou, CN Shenzhen Shi, CN Shenzhen Shi, CN Suzhou Shi, CN see more | Locations Incheon, KR HQ |
Employees | Employees 6 | Employees 82517% decrease | Employees 27214% decrease | Employees 1113% increase | Employees 6301% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 648.3 m | Valuation ($) 136.8 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩2t (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods €9.7m (FY, 2024) | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A | Cost of goods ₩1.4t (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit €534.4m (FY, 2024) | Gross profit $170.2m (FY, 2025) | Gross profit N/A | Gross profit ₩664.7b (FY, 2022) |
Net income | Net income N/A | Net income €162.2m (FY, 2024) | Net income N/A | Net income N/A | Net income ₩147.2b (FY, 2022) |
Funding | |||||
Latest funding round | Latest funding round $ 10m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 7.6m (about 14 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 16m | Total funding raised $ 1.1b | Total funding raised $ 172m | Total funding raised $ 12.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyPuma Biotechnology
HQ
Los Angeles, US
Employees
272↓ 14% decrease
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
View companyHUYA Bioscience International
HQ
San Diego, US
Employees
111↑ 3% increase
HUYA Bioscience International is a company specializing in the biopharmaceutical products.
View companyCelltrion Healthcare
HQ
Incheon, KR
Employees
630↑ 1% increase
Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis.,
View company